Stock listing

REGN Stock Price, News, Filings & Events — Regeneron Pharmaceuticals, Inc.

Selected listing: REGN · VIE · EUR · AT

This page tracks Regeneron Pharmaceuticals, Inc.'s REGN:VIE listing on VIE in EUR for AT, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following REGN:VIE. REGN:VIE is the stock-level entry point for investors researching Regeneron Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Regeneron Pharmaceuticals, Inc. is a public company traded on the American stock market under the ticker REGN. The company has a market capitalization of approximately $68.8 billion. Regeneron focuses on developing and commercializing innovative medicines for serious diseases.

REGN:VIEEURATUpdated August 21, 2026

Ticker: REGN:VIE
Asset type: Stock
Market cap: $85.87B
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: VIE
Currency: EUR

Regeneron Pharmaceuticals, Inc. REGN:VIE stock context

Latest news from Regeneron Pharmaceuticals, Inc.

Veeva Vault CRM Selected by Regeneron

August 25, 2026

Pasatru™ (garetosmab-grts) First and Only FDA-approved Treatment Demonstrating Reduction in New Heterotopic Ossification (HO) Lesions and...

August 19, 2026

Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation

July 31, 2026

Regeneron Reports Second Quarter 2026 Financial and Operating Results

July 30, 2026

Regeneron to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast

June 25, 2026

All Regeneron Pharmaceuticals, Inc. news →

Research Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. investor report

Review AI stock analysis and investor report context for REGN:VIE.

Regeneron Pharmaceuticals, Inc. company profile

View the public company page for Regeneron Pharmaceuticals, Inc. on 6ix.

Regeneron Pharmaceuticals, Inc. news

Read company news and market updates connected to Regeneron Pharmaceuticals, Inc..

Regeneron Pharmaceuticals, Inc. investor events

Find investor webinars, events, and replay context for Regeneron Pharmaceuticals, Inc..